Header Logo

Connection

CHING-WEI DAVID TZENG to Infusions, Intravenous

Back to Details
This is a "connection" page, showing publications CHING-WEI DAVID TZENG has written about Infusions, Intravenous.
CHING-WEI DAVID TZENG
Connection Strength
0.038
Infusions, Intravenous
  1. Pilot Clinical Trial of Perioperative Durvalumab and Tremelimumab in the Treatment of Resectable Colorectal Cancer Liver Metastases. Clin Cancer Res. 2021 06 01; 27(11):3039-3049.
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.